Aclarion, Inc. (ACON) は上場企業です ヘルスケア セクターの Medical - Healthcare Information Services 業界で事業展開. 本社所在地は Broomfield, CA, アメリカ. 現CEOは Brent Ness.
ACON を有する IPO日 2022-04-22, 5 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $1.74M.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
